Athira Pharma, Inc.
Athira Pharma, Inc.（ATHA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
atha · 股价预测 · 5 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Hold
5 位分析师
共识
评级分布
12 个月目标价
High
$33.00
Consensus
$13.33
+178.3% upside
Low
$3.00
Median: $4 · Last Close: $4.79
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$13.33
178.3% upside
High Target
$33
588.9%
Low Target
$3
-37.4%
Current Price
$4.79
as of today
Based on analyst price targets, the ATHA stock price prediction for the next 12 months ranges from $3 to $33. The consensus ATHA price forecast of $13.33 implies 178.3% upside from the current price of $4.79.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.55 | ↓ 5.00% |
1-day model range: $4.46–$4.64. Peak: $4.64 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ATHA · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-09-19 | Mizuho | Downgrade ↓ | Outperform→Neutral |
| 2024-09-04 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2024-09-04 | BTIG | Downgrade ↓ | Buy→Neutral |
| 2024-06-20 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2024-05-16 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2023-08-11 | JMP Securities | Maintains | Outperform→Outperform |
| 2023-05-15 | Mizuho | Maintains | Buy→Buy |
| 2023-03-30 | BTIG | Maintains | Buy→Buy |
| 2022-06-23 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2022-06-23 | Stifel | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Athira Pharma, Inc. (ATHA) stock. Of the recent 11 rating actions, 0 were upgrades and 6 were downgrades. 5 analysts currently cover ATHA.
分析师推荐趋势
ATHA analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
Revenue Next Year
$13M
EPS This Year
$-6.24
EPS Next Year
$-4.87
↓ 22.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ATHA EPS of $-6.24 for the current fiscal year, based on estimates from 1 analysts. The ATHA revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ATHA 股价预测由两类独立数据源支撑：来自 5 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ATHA 的共识目标价为 $13.33（+178.3% 上行空间），分析师共识为 Hold。
ATHA 的短期预测（明日）为 $4.55（-5.00%）。
Athira Pharma, Inc. 在 NASDAQ 上市，代码 ATHA。ATHA 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 0% 对应 Hold 共识。
常见问题
ATHA 预测 · 8 个问题根据 5 位华尔街分析师，ATHA 的 12 个月平均目标价为 $13.33，最高 $33.00、最低 $3.00。若有图表，中位目标价可在上方查看。相对当前价 $4.79，隐含约 +178.3% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.